Serum Clusterin and Complement Factor H May Be Biomarkers Differentiate Primary Sjögren's Syndrome With and Without Neuromyelitis Optica Spectrum Disorder
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a neurological complication of primary Sjögren's syndrome (pSS).Objective: We aimed to explore potential serological differences between pSS patients with and without NMOSD.Methods: There were 4 pSS patients with NMOSD and 8 pSS pati...
Main Authors: | Lin Qiao, Chuiwen Deng, Qian Wang, Wen Zhang, Yunyun Fei, Yan Xu, Yan Zhao, Yongzhe Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02527/full |
Similar Items
-
Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report
by: Carlos Alva Díaz, et al.
Published: (2016-03-01) -
Primary Sjögren's syndrome patients with neuromyelitis optica spectrum disorders: clinical analysis of 4 cases and review of the literature
by: Jing-jiong CHEN, et al.
Published: (2013-05-01) -
The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review
by: A V Torgashina, et al.
Published: (2018-05-01) -
Neuromyelitis optica spectrum disorders in pediatric patients
by: Yu. V. Tokareva, et al.
Published: (2018-04-01) -
Neuromyelitis optica spectrum standstill in rheumatic systemic autoimmune diseases
by: Basant Elnady, et al.
Published: (2020-10-01)